尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by DeSchuytner Brian, 首席财务官. Insider active across 1 company, notably Mersana Therapeutics, Inc.. Aggregated, 8 disclosures have been recorded. History available since 14 January 2023. The latest transaction was filed on 15 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
DeSchuytner Brian is Directeur Financier at Mersana Therapeutics, Inc., where he is also SVP, COO & CFO. He has 8 filings in total, and the sampled most recent filings cover the period from 2022-01-19 to 2026-01-06, with option exercises as the transaction type.